Practice question
Answer the question and get instant feedback.
Moderate"CDC/ACIP recommends 2 doses of recombinant zoster vaccine (Shingrix) separated by 2-6 months for all immunocompetent adults ≥50 years. Zostavax (A) is discontinued. Single dose (B) is insufficient. Not limited to immunocompromised (D) or ≥75 (E)."Infectious Diseases"easy"
Educational content. Not a substitute for clinical judgement or local policy.